                         SEQUENCE LISTING

<110>  Mologen AG
 
<120>  TLR-9 AGONIST FOR MODULATION OF TUMOR MICROENVIRONMENT

<130>  59 814 K

<150>  EP 17 001 465.8
<151>  2017-08-31

<150>  EP 18 151 734.3
<151>  2018-01-15

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Partial sequence of Lefitolimod

<400>  1
cctaggggtt accaccttca ttggaaaacg ttcttcgggg cgttcttagg tggtaacc         58


<210>  2
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Partial sequence of dSLIM 2006

<400>  2
aggtggtaac ccctaggggt taccaccttc atcgtcgttt tgtcgttttg tcgttctt         58


<210>  3
<211>  116
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Complete sequence of Lefitolimod

<400>  3
aaaacgttct tcggggcgtt cttaggtggt aacccctagg ggttaccacc ttcattggaa       60

aacgttcttc ggggcgttct taggtggtaa cccctagggg ttaccacctt cattgg          116


<210>  4
<211>  116
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Complete sequence of dSLIM 2006

<400>  4
tcatcgtcgt tttgtcgttt tgtcgttctt aggtggtaac ccctaggggt taccaccttc       60

atcgtcgttt tgtcgttttg tcgttcttag gtggtaaccc ctaggggtta ccacct          116


<210>  5
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 31 and 32: in L-configuration

<400>  5
ggggtcatta aaacgtgacg tgacgttctt ttt                                    33


<210>  6
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 1, 2, 35 and 36: in L-configuration

<400>  6
ggggggggtc attaaaacgt gacgtgacgt tcttttt                                37


<210>  7
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 30 and 31: in L-configuration

<400>  7
ggggtcatta aacgtgacgt gacgttcttt tt                                     32


<210>  8
<211>  34
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 32 and 33: in L-configuration

<400>  8
ggggtcatta aacgttcttc ggggcgttct tttt                                   34


<210>  9
<211>  39
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 37 and 38: in L-configuration

<400>  9
ggggtcatta aatcgtcgtt ttgtcgtttt gtcgttttt                              39


<210>  10
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 1, 2, 19 and 20: in L-configuration

<400>  10
gggggacgat cgtcgggggg t                                                 21


<210>  11
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 31 and 32: in L-configuration

<400>  11
gggtcattaa acgttcttcg gggcgttctt ttt                                    33


<210>  12
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 1, 2, 36 and 37: in L-configuration

<400>  12
ggggggggtc attaaacgtt cttcggggcg ttcttttt                               38


<210>  13
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 1, 2, 34 and 35: in L-configuration

<400>  13
ggggggggtc attaaacgtg acgtgacgtt cttttt                                 36


<210>  14
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR-9 agonist comprising at least one nucleotide in 
       L-configuration


<220>
<221>  misc_feature
<223>  Nucleotides 1, 2, 41 and 42: in L-configuration

<400>  14
ggggggggtc attaaatcgt cgttttgtcg ttttgtcgtt ttt                         43


